Prior to his current role, Peter has been the CEO of GE Central and Eastern Europe (CEE) since 2013, responsible for GE’s growth strategy and leading a team of more than 20,000 people across manufacturing, sourcing, sales and other functions.
- Acquires 75% controlling stake in the two stage 365 MW Persimmon wind project in joint venture with Elawan Wind
- GE provides wind turbines and tax equity
- GE, CIT, MUFG and Rabobank provide construction financing
New York, NY - January 16, 2018 - Quinbrook Infrastructure Partners ("Quinbrook"), a global investment manager specializing in lower carbon and renewable energy infrastructure assets and GE (NYSE: GE) today announced that the Quinbrook Low Carbon Power Fund has closed construction and tax equity financing of the 200 Megawatt
business unit
CHALFONT ST. GILES, UK, 11 January 2018 - GE Healthcare announced today the approval in Canada of DaTscan™ (Ioflupane I 123 Injection), the first Health Canada approved radiopharmaceutical adjunct imaging agent to help physicians evaluate patients with a suspected parkinsonian syndrome (PS) such as Parkinson’s disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). DaTscan is unable to discriminate between PD, MSA and PSP.
business unit
- New Technology and Equipment Enhance Performance, Increase Capacity
Dallas, TX -- January 11, 2018 -- Leeward Renewable Energy, LLC ("Leeward") and GE (NYSE: GE) today announced the successful completion of the repowering of the combined capacity 136 MW Sweetwater 1 & 2 wind farms in Nolan County, Texas. GE Renewable Energy is the wind turbine provider for the project and GE Energy Financial Services provided tax equity financing.
business unit
- GE Power will provide two 9F.05 gas turbines, and Harbin Electric (HE) will provide steam turbines, generators and auxiliary systems
- GE’s 9F.05 gas turbine is an ideal fit to support China’s latest environmental policies encouraging more efficient power generation using cogeneration (CHP) solutions
- GE and HE’s local manufacturing and services capabilities will help reduce project costs
Beijing, CHINA - January 8, 2018
business unit
tags
- Companies aim to develop jointly-branded clinical decision support software for faster, more accurate, more confident decision-making, enabling earlier diagnosis and individualized treatment
- Partnership will apply advanced analytics to in-vivo data from GE’s medical imaging and monitoring equipment with in-vitro data from Roche’s biomarker, tissue pathology, genomics and sequencing portfolio
Chicago, USA Jan 8, 2018 - GE Healthcare has entered into a strategic, long-term partnership with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointl